Impact of acute consumption of beverages containing plant-based or alternative sweetener blends on postprandial appetite, food intake, metabolism, and gastro-intestinal symptoms: Results of the SWEET beverages trial.
Glycaemic response
Insulin
Lipids
Satiety
Sweetness enhancer
Journal
Appetite
ISSN: 1095-8304
Titre abrégé: Appetite
Pays: England
ID NLM: 8006808
Informations de publication
Date de publication:
01 05 2023
01 05 2023
Historique:
received:
23
11
2022
revised:
24
02
2023
accepted:
24
02
2023
pubmed:
28
2
2023
medline:
22
3
2023
entrez:
27
2
2023
Statut:
ppublish
Résumé
Project SWEET examined the barriers and facilitators to the use of non-nutritive sweeteners and sweetness enhancers (hereafter "S&SE") alongside potential risks/benefits for health and sustainability. The Beverages trial was a double-blind multi-centre, randomised crossover trial within SWEET evaluating the acute impact of three S&SE blends (plant-based and alternatives) vs. a sucrose control on glycaemic response, food intake, appetite sensations and safety after a carbohydrate-rich breakfast meal. The blends were: mogroside V and stevia RebM; stevia RebA and thaumatin; and sucralose and acesulfame-potassium (ace-K). At each 4 h visit, 60 healthy volunteers (53% male; all with overweight/obesity) consumed a 330 mL beverage with either an S&SE blend (0 kJ) or 8% sucrose (26 g, 442 kJ), shortly followed by a standardised breakfast (∼2600 or 1800 kJ with 77 or 51 g carbohydrates, depending on sex). All blends reduced the 2-h incremental area-under-the-curve (iAUC) for blood insulin (p < 0.001 in mixed-effects models), while the stevia RebA and sucralose blends reduced the glucose iAUC (p < 0.05) compared with sucrose. Post-prandial levels of triglycerides plus hepatic transaminases did not differ across conditions (p > 0.05 for all). Compared with sucrose, there was a 3% increase in LDL-cholesterol after stevia RebA-thaumatin (p < 0.001 in adjusted models); and a 2% decrease in HDL-cholesterol after sucralose-ace-K (p < 0.01). There was an impact of blend on fullness and desire to eat ratings (both p < 0.05) and sucralose-acesulfame K induced higher prospective intake vs sucrose (p < 0.001 in adjusted models), but changes were of a small magnitude and did not translate into energy intake differences over the next 24 h. Gastro-intestinal symptoms for all beverages were mostly mild. In general, responses to a carbohydrate-rich meal following consumption of S&SE blends with stevia or sucralose were similar to sucrose.
Identifiants
pubmed: 36849009
pii: S0195-6663(23)00068-5
doi: 10.1016/j.appet.2023.106515
pii:
doi:
Substances chimiques
Blood Glucose
0
Cholesterol
97C5T2UQ7J
Sucrose
57-50-1
Sweetening Agents
0
Banques de données
ClinicalTrials.gov
['NCT04483180']
Types de publication
Randomized Controlled Trial
Multicenter Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
106515Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest JCGH, JAH, and CAH and are in receipt of research funding from the American Beverage Association; MMR and CEH's research centre provides consultancy to, and has received travel funds to present research results from organisations supported by food and beverage companies. ARA has received honoraria from Nestlé, Unilever and the International Sweeteners Association. CAH has received honoraria from the International Sweeteners Association. CS is an employee of Cargill, Inc. The other authors have nothing to declare.